Fluoxetine reverses depressive-like behaviors and increases hippocampal acetylcholinesterase activity induced by olfactory bulbectomy

Pharmacology Biochemistry and Behavior

Volumn 103, Issue 2, 2012, Pages 220-229

  MacHado, Daniele G ^a   Cunha, Mauricio P ^a   Neis, Vivian B ^a   Balen, Grasiela O ^a   Colla, André ^a   Grando, Jaine ^a   Brocardo, Patricia S ^a   Bettio, Luis E B ^a   Capra, Juliano C ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Acetylcholinesterase; Fluoxetine; Hyperactivity; Olfactory bulbectomy; Splash test

Indexed keywords

ACETYLCHOLINESTERASE; FLUOXETINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; EXPLORATORY BEHAVIOR; FEMALE; HIPPOCAMPUS; LOCOMOTION; MOTIVATION; MOUSE; NONHUMAN; OLFACTORY BULBECTOMY; OPEN FIELD TEST; PRIORITY JOURNAL; SELF CARE;

ACETYLCHOLINESTERASE; ANIMALS; BEHAVIOR, ANIMAL; CORTICOSTERONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOXETINE; HIPPOCAMPUS; MICE; OLFACTORY BULB; SEROTONIN UPTAKE INHIBITORS;

ANIMALIA; MUS;

EID: 84866289785     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.08.024     Document Type: Article

References (69)

1. C. Bellver, P. Rubio, P. Tarrio, and B.E. Leonard Effect of some new antidepressants on learned helplessness and olfactory bulbectomy models of depression Eur J Pharmacol 183 1990 2056 2057
2. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
3. P.S. Brocardo, J. Budni, M.P. Kaster, A.R.S. Santos, and A.L.S. Rodrigues Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems Neuropharmacology 54 2008 464 473
4. C.L. Broekkamp, W.T. O'Connor, J.A.D.M. Tonnaer, H.W. Rijk, and A.M.L. Van Delft Corticosterone, choline acetyltransferase and noradrenaline levels in olfactory bulbectomized rats in relation to changes in passive avoidance and open field activity Physiol Behav 37 1986 429 434
5. J. Butler, and B.E. Leonard Clinical and experimental studies on fluoxetine: effects on serotonin uptake Int Clin Psychopharmacol 5 1990 41 48
6. K.D. Cairncross, A. Wren, B. Cox, and H. Schnieden Effects of olfactory bulbectomy and domicile on stress-induced corticosterone release in the rat Physiol Behav 19 1977 485 487
7. V.P. Carlini, D.G. Machado, F. Buteler, M. Ghersi, M.F. Ponzio, and A.C. Martini Acute ghrelin administration reverses depressive-like behavior induced by bilateral olfactory bulbectomy in mice Peptides 35 2012 160 165
8. M.P. Cunha, D.G. Machado, L.E.B. Bettio, J.C. Capra, and A.L.S. Rodrigues Interaction of zinc with antidepressants in the tail suspension test Prog Neuropsychopharmacol Biol Psychiatry 32 2008 1913 1920
9. G. Dagytė, J.A. Den Boer, and A. Trentani The cholinergic system and depression Behav Brain Res 221 2011 574 582
10. A.C. d'Audiffret, S.J. Frisbee, P.A. Stapleton, A.G. Goodwill, E. Isingrini, and J.C. Frisbee Depressive behavior and vascular dysfunction: a link between clinical depression and vascular disease? J Appl Physiol 108 2010 1041 1051
11. D.J. David, B.A. Samuels, Q. Rainer, J.W. Wang, D. Marsteller, and I. Mendez Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression Neuron 62 2009 479 493
12. B.C. Detanico, A.L. Piato, J.J. Freitas, F.L. Lhullier, M.P. Hidalgo, and W. Caumo Antidepressant-like effects of melatonin in the mouse chronic mild stress model Eur J Pharmacol 607 2009 121 125
13. W.C. Drevets, J.L. Price, and M.L. Furey Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression Brain Struct Funct 213 2008 93 118
14. G.E. Duncan, D.J. Knapp, S.W. Carson, and G.R. Breese Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone J Pharmacol Exp Ther 285 1998 579 587
15. N. Egashira, Y. Matsumoto, K. Mishima, K. Iwasaki, M. Fujioka, and M. Matsushita Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization Pharmacol Biochem Behav 83 2006 161 167
16. G.L. Ellman, K.D. Courtney, V.J. Andres, and R.M. Featherstone A new rapid colorimetric determination of acetylcholinesterase activity Biochem Pharmacol 7 1961 88 95
17. P.W. Gold, and G.P. Chrousos Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states Mol Psychiatry 7 2002 254 275
18. A. Harkin, J.P. Kelly, and B.E. Leonard A review of the relevance and validity of olfactory bulbectomy as a model of depression Clin Neurosci Res 3 2003 253 262
19. R. Hellweg, M. Zueger, K. Fink, H. Hörtnagl, and P. Gass Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas Neurobiol Dis 25 2007 1 7
20. E. Isingrini, V. Camus, A.M. Le Guisquet, M. Pingaud, S. Devers, and C. Belzung Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice PLoS One 5 2010 e10404
21. S. Jancsar, and B.E. Leonard The effect of antidepressants on conditioned taste aversion learning in the olfactory bulbectomized rat Neuropharmacology 20 1981 1314 1315
22. J. Jarosik, B. Legutko, K. Unsicker, and O. von Bohlen und Halbach Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy Exp Neurol 204 2007 20 28
23. J.A. Jesberger, and J.S. Richardson Brain output dysregulation induced by olfactory bulbectomy: an approximation in the rat of major depressive disorder in humans? Int J Neurosci 38 1988 241 265
24. A.V. Kalueff, and P. Tuohimaa Experimental modeling of anxiety and depression Acta Neurobiol Exp (Wars) 64 2004 439 448
25. J.P. Kelly, A.S. Wrynn, and B.E. Leonard The olfactory bulbectomized rat as a model of depression: an update Pharmacol Ther 74 1997 299 316
26. V. Krishnan, and E.J. Nestler The molecular neurobiology of depression Nature 455 2008 894 902
27. B.E. Leonard The olfactory bulbectomized rat as a model of depression Pol J Pharmacol Pharm 36 1984 561 569
28. B.E. Leonard, and M. Tuite Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat Int Rev Neurobiol 22 1981 251 286
29. K.R. Lobato, C.C. Cardoso, R.W. Binfaré, J. Budni, C.L. Wagner, and P.S. Brocardo Alpha-tocopherol administration produces an antidepressant-like effect in predictive animal models of depression Behav Brain Res 209 2010 249 259
30. A.R. Lumia, M.H. Teicher, F. Salchli, E. Ayers, and B. Possidente Olfactory bulbectomy as a model for agitated hyposerotonergic depression Brain Res 587 1992 181 185
31. D.G. Machado, M.P. Kaster, R.W. Binfaré, M. Dias, A.R.S. Santos, and M.G. Pizzolatti Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system Prog Neuropsychopharmacol Biol Psychiatry 31 2007 421 428
32. D.G. Machado, L.E.B. Bettio, M.P. Cunha, J.C. Capra, J.B. Dalmarco, and M.G. Pizzolatti Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system Prog Neuropsychopharmacol Biol Psychiatry 33 2009 642 650
33. A. Mar, E. Spreekmeester, and J. Rochford Antidepressants preferentially enhance habituation to novelty in the olfactory bulbectomized rat Psychopharmacology 150 2000 52 60
34. A. Mar, E. Spreekmeester, and J. Rochford Fluoxetine-induced increases in open field habituation in the olfactory bulbectomized rat depend on test aversiveness but not on anxiety Pharmacol Biochem Behav 73 2002 703 712
35. A. Marcilhac, M. Faudon, G. Anglade, F. Hery, and P. Siaud An investigation of serotonergic involvement in the regulation of ACTH and corticosterone in the olfactory bulbectomized rat Pharmacol Biochem Behav 63 1999 599 605
36. C.E. Marx, L.J. Shampine, R.T. Khisti, W.T. Trost, D.W. Bradford, and A.C. Grobin Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions Pharmacol Biochem Behav 84 2006 609 617
37. Y.S. Mineur, and M.R. Picciotto Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis Trends Pharmacol Sci 31 2010 580 586
38. M. Moretti, A. Colla, G. de Oliveira Balen, D.B. dos Santos, J. Budni, and A.E. de Freitas Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress J Psychiatr Res 46 2012 331 340
39. S. Moriguchi, F. Han, O. Nakagawasai, T. Tadano, and K. Fukunaga Decreased calcium/calmodulin-dependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice J Neurochem 97 2006 22 29
40. T.C. Müller, J.B. Rocha, V.M. Morsch, R.T. Neis, and M.R. Schetinger Antidepressants inhibit human acetylcholinesterase and butyrylcholinesterase activity Biochim Biophys Acta 1587 2002 92 98
41. A. Nakajima, T. Yamakuni, M. Haraguchi, N. Omae, S. Song, and C. Kato Nobiletin, a citrus flavonoid that improves memory impairment, rescues bulbectomy-induced cholinergic neurodegeneration in Mice J Pharmacol Sci 105 2007 122 126
42. E.J. Nestler, M. Barrot, R.J. DiLeone, A.J. Eisch, S.J. Gold, and L.M. Monteggia Neurobiology of depression Neuron 34 2002 13 25
43. R.D. Porsolt, A. Bertin, N. Blavet, M. Deniel, and M. Jalfre Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity Eur J Pharmacol 57 1979 201 210
44. B. Possidente, A.R. Lumia, M.Y. McGinnis, M. Rapp, and S. McEldowney Effects of fluoxetine and olfactory bulbectomy on mouse circadian activity rhythms Brain Res 713 1996 108 113
45. M. Roche, A. Harkin, and J.P. Kelly Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat Neuropsychopharmacology 32 2007 1312 1320
46. A. Rodríguez-Gaztelumendi, M.L. Rojo, A. Pazos, and A. Díaz Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine J Neurochem 108 2009 1423 1433
47. T. Romeas, M.C. Morissette, O. Mnie-Filali, G. Piñeyro, and S.M. Boye Simultaneous anhedonia and exaggerated locomotor activation in an animal model of depression Psychopharmacology 205 2009 293 303
48. K. Scearce-Levie, J.P. Chen, E. Gardner, and R. Hen 5-HT receptor knockout mice: pharmacological tools or models of psychiatric disorders Ann N Y Acad Sci 868 1999 701 715
49. M. Serra, M.G. Pisu, M. Muggironi, V. Parodo, G. Papi, and R. Sari Opposite effects of short- versus long-term administration of fluoxetine on the concentrations of neuroactive steroids in rat plasma and brain Psychopharmacology (Berl) 158 2001 48 54
50. N. Shioda, Y. Yamamoto, F. Han, S. Moriguchi, Y. Yamaguchi, and M. Hino A novel cognitive enhancer, ZSET1446/ST101, promotes hippocampal neurogenesis and ameliorates depressive behavior in olfactory bulbectomized mice J Pharmacol Exp Ther 333 2010 43 50
51. C. Song, and B.E. Leonard The olfactory bulbectomised rat as a model of depression Neurosci Biobehav Rev 29 2005 627 647
52. H.S. Stock, K. Ford, and M.A. Wilson Gender and gonadal hormone effects in the olfactory bulbectomy animal model of depression Pharmacol Biochem Behav 67 2000 183 191
53. H.S. Stock, G.A. Hand, K. Ford, and M.A. Wilson Changes in defensive behaviors following olfactory bulbectomy in male and female rats Brain Res 903 2001 242 246
54. S. Taylor, and M.B. Stein The future of selective serotonin reuptake inhibitors (SSRIs) in psychiatric treatment Med Hypotheses 66 2006 14 21
55. S.C. Tiwari, J.S. Siddiqu, N. Tuteja, N. Lal, J.K. Trivedi, and L.M. Bahuguna Serum acetylcholinesterase activity in psychiatric patients Indian J Psychiatry 24 1982 291 294
56. V. Uzunova, A.S. Wrynn, A. Kinnunen, M. Ceci, C. Kohler, and D.P. Uzunov Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat Eur J Pharmacol 486 2004 31 34
57. J. Van Hoomissen, J. Kunrath, R. Dentlinger, A. Lafrenz, M. Krause, and A. Azar Cognitive and locomotor/exploratory behavior after chronic exercise in the olfactory bulbectomy animal model of depression Behav Brain Res 222 2011 106 116
58. H. Van Riezen, and B.E. Leonard Effects of psychotropic drugs on the behaviour and neurochemistry of olfactory bulbectomized rats Pharmacol Ther 47 1990 21 34
59. R.N. Walsh, and R.A. Cummins The open-field test: a critical review Psychol Bull 83 1976 482 504
60. C.C. Weber, G.P. Eckert, and W.E. Müller Effects of antidepressants on the brain/plasma distribution of corticosterone Neuropsychopharmacology 31 2006 2443 2448
61. C.A. Winstanley, J.W. Dalley, D.E. Theobald, and T.W. Robbins Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior Neuropsychopharmacology 29 2004 1331 1343
62. O.M. Wolkowitz, H. Burke, E.S. Epel, and V.I. Reus Glucocorticoids. Mood, memory, and mechanisms Ann N Y Acad Sci 1179 2009 19 40
63. M.L. Wong, and J. Licinio Research and treatment approaches to depression Nat Rev Neurosci 2 2001 343 351
64. D.T. Wong, K.W. Perry, and F.P. Bymaster Case history: the discovery of fluoxetine hydrochloride (Prozac) Nat Rev Drug Discov 4 2005 764 774
65. A.S. Wrynn, C.P. Mac Sweeney, F. Franconi, L. Lemaire, D. Pouliquen, and S. Herlidou An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression Brain Res 879 2000 193 199
66. I. Yalcin, F. Aksu, and C. Belzung Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol Eur J Pharmacol 514 2005 165 174
67. I. Yalcin, C. Belzung, and A. Surget Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey Behav Brain Res 193 2008 140 143
68. M. Yamada, M. Hayashida, Q. Zhao, N. Shibahara, K. Tanaka, and T. Miyata Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice J Ethnopharmacol 135 2011 737 746
69. M. Zueger, A. Urani, S. Chourbaji, C. Zacher, M. Roche, and A. Harkin Olfactory bulbectomy in mice induces alterations in exploratory behavior Neurosci Lett 374 2005 142 146